Current Management of Alcohol-Associated Liver Disease.
| Autor: | Siddiqi FA; Department of Hospital Medicine, Ochsner Medical Center, New Orleans, Louisiana., Sajja KC; Division of Gastroenterology and Hepatology, Ochsner Medical Center, New Orleans, Louisiana., Latt NL; Division of Gastroenterology and Hepatology, University Hospital, Rutgers New Jersey Medical School, Newark, New Jersey. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Gastroenterology & hepatology [Gastroenterol Hepatol (N Y)] 2020 Nov; Vol. 16 (11), pp. 561-570. |
| Abstrakt: | Alcohol consumption is a major risk factor for various diseases worldwide and is one of the most common causes of chronic liver disease. Alcohol use has risen over the past 30 years and is forecast to continue to rise. Concurrently, there has been an increased incidence of alcohol-associated liver disease (ALD). Alcohol use, regardless of the amount, leads to years of health loss across populations when considering the strong association between alcohol consumption and overall disease burden. Given the rising incidence of ALD and associated mortality, it is imperative to study the underlying factors driving these trends. This article summarizes the diagnosis and management of ALD, with a focus on various screening and prognostic tools and treatments for alcohol-associated hepatitis. Competing Interests: The authors have no relevant conflicts of interest to disclose. (Copyright © 2020, Gastro-Hep Communications, Inc.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|